Sign in
Not yet recruitingNo phase

Efficacy of Myopia-control Lenses in a Population of Young Adults : the OPTIMA Study

Key facts

Who runs it
Fondation Ophtalmologique Adolphe de Rothschild
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
134 people, planned
Started
1 Nov 2026
Expected to end
1 Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Essilor® Stellest® 2.0 myopia-slowing lenses
  • Standard lenses
Record updated
4 September 2026

Who can take part

Age
16 years to 25 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Spherical equivalent (SE) measured under cycloplegia using an autorefractometer, within the range 4 D ≤ SE ≤ -0.75 D for each eye
  • Not currently receiving, nor having received, any preventive treatment for myopic progression in the 12 months prior to inclusion (orthokeratology, soft defocus contact lenses, low-concentration atropine eye drops, corrective spectacles with peripheral defocus)
  • Myopic progression of at least -0.25 D in at least one eye during the year prior to inclusion (measurements documented by autorefractometer, with or without cycloplegia, or via previous optical prescriptions) or documented progression of axial length of +0.1 mm during the year prior to inclusion
  • Primary optical correction via spectacles (occasional use of contact lenses if applicable) or agreement to wear spectacles for at least 12 hours a day, every day
  • Enrolled in or a beneficiary of a social security scheme
  • Signed informed consent to participate in the study by the adult patient or by a person with parental authority for minor patients

Who cannot take part

  • Participation in another interventional clinical trial (drug clinical trial)
  • A history of eye surgery (excluding eyelid surgery) in at least one eye
  • Advanced retinal disease in at least one eye, such as myopic maculopathy
  • Confirmed syndromic myopia or findings suggestive of syndromic myopia
  • Obvious strabismus or significant heterophoria
  • Corrected visual acuity < 8/10 in at least one eye
  • Hyperopia or non-myopic astigmatism
  • Anisometropia, i.e. a marked difference in correction between the two eyes
  • Specific visual impairments in at least one eye requiring personalised treatments other than conventional corrective lenses
  • Intolerance to optical corrections (conventional lenses or lenses with peripheral defocus)
  • Patients subject to legal protection measures
  • Pregnant or breastfeeding women

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 16 and 25 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if myopia-control eyeglass lenses (Essilor® Stellest® 2.0) can slow down the progression of short-sightedness (myopia) in young adults, compared with standard single-vision lenses. The main questions it aims to answer are:

Read full original descriptionShow less

Does wearing Stellest® 2.0 lenses slow the increase in eye length (axial length) after 1 year, compared with standard lenses? Does wearing Stellest® 2.0 lenses reduce the change in glasses prescription and the occurrence of eye complications after 2 years, compared with standard lenses? How well do participants tolerate the Stellest® 2.0 lenses in the first weeks of wear? Researchers will compare Stellest® 2.0 myopia-control lenses to standard single-vision lenses to see if they reduce the worsening of myopia.

Participants will:

Wear either the study glasses or standard glasses every day, at least 12 hours a day, for 2 years Attend an eye exam and vision check at the start of the study, after 1 year, and after 2 years Complete three phone check-ins during the first 3 months to report on comfort and how well they tolerate their glasses

The 2 groups in the trial

  • Essilor® Stellest® 2.0 myopia-slowing lensesTreatment being tested
  • standard lensesExisting treatment, for comparison

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacité de Verres de Freination Myopique Dans Une Population de Jeunes Adultes
Criteria questions
Built from NCT07804043, who can take part
Record updated
4 September 2026